戻る Agenda
SESSION 4: SIGNAL MANAGEMENT PROCESS: STRATEGY FOR IMPLEMENTATION (1)
Session Chair(s)
Philip Jones
Disease Area Cluster Lead in Safety Surveillance and Risk Management
Pfizer Ltd., United Kingdom
This session reviews how regulators, big companies and small companies should design their signal management process, the expected timelines, resources and outcomes from this process, and how the communication of signals should be performed. We will discuss all of these critical issues during this final session, and look at the typical scenarios the industry and regulators face today.
Speaker(s)
SIGNAL MANAGEMENT PROCESS: STRATEGY FOR IMPLEMENTATION
Philip Jones
Pfizer Ltd., United Kingdom
Disease Area Cluster Lead in Safety Surveillance and Risk Management